YD Bio Limited (YDESW)Taipei, Taiwan | NasdaqGM
0.25 USD
+0.01
(4.167%)
⇧
(July 13, 2026, 4 p.m.
EDT)
|
Hot Take ↕ | July 11, 2026, 3:17 a.m. EDT
The security has too little price history to assess long-term trends, leaving the multi-year trajectory neutral despite a massive 95.6% surge in revenue growth. This top-line expansion is currently being completely erased by catastrophic operational inefficiencies, with operating margins collapsing to -445% and free cash flow turning massively negative at -$3.8 million. While the balance sheet appears fortified with a current ratio of 13x and negligible debt relative to equity, the company is burning cash aggressively to fuel this growth, resulting in negative returns on both assets and equity. With no dividend to provide income and no established track record of profitability, the investment case relies entirely on the assumption that this hyper-growth phase will eventually convert into sustainable earnings without further capital dilution or operational hemorrhaging. |
| Attribute | Value |
|---|---|
| Debt to Equity Ratio | 0.338 |
| Revenue per Share | 0.466 |
| Beta | -0.13 |
| Profit Margins | -276.58% |
| Previous Name | Breeze Holdings Acquisition Corp. |
| Website | https://www.ydesgroup.com |
| Attribute | Value |
|---|---|
| Address1 | No. 3, Xingnan St. |
| Address2 | 12F. Nangang Dist. |
| Ask | 0.4499 |
| Ask Size | 1 |
| Beta | -0.127 |
| Bid | 0.5493 |
| Bid Size | 1 |
| Book Value | 4.571 |
| City | Taipei |
| Country | Taiwan |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 0.25 |
| Current Ratio | 13.183 |
| Custom Price Alert Confidence | HIGH |
| Day High | 0.2561 |
| Day Low | 0.25 |
| Debt To Equity | 0.338 |
| Display Name | YD Bio |
| Ebitda | -1,357,195 |
| Ebitda Margins | -2.6592898 |
| Esg Populated | 0 |
| Exchange | NGM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Two Week High | 0.2561 |
| Fifty Two Week High Change | -0.006099999 |
| Fifty Two Week High Change Percent | -0.023818817 |
| Fifty Two Week Low | 0.25 |
| Fifty Two Week Low Change | 0.0 |
| Fifty Two Week Low Change Percent | 0.0 |
| Fifty Two Week Range | 0.25 - 0.2561 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,783,690,200,000 |
| Float Shares | 319,740 |
| Free Cashflow | -3,875,569 |
| Full Exchange Name | NasdaqGM |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.3044 |
| Gross Profits | 155,356 |
| Has Pre Post Market Data | 1 |
| Industry | |
| Industry Key | |
| Ipo Expected Date | 2,025-08-29 |
| Language | en-US |
| Long Business Summary | YD Bio Limited a biopharmaceutical company focuses on blood-based cancer detection and develops stem cell- and exosome-based therapeutics to transform the treatment of spectrum of diseases with unmet medical needs. The company is based in Taipei, Taiwan. |
| Long Name | YD Bio Limited |
| Market | us_market |
| Market State | POSTPOST |
| Max Age | 86,400 |
| Message Board Id | finmb_1898493574 |
| Name Change Date | 2,026-07-13 |
| Net Income To Common | -1,411,559 |
| Open | 0.2561 |
| Operating Cashflow | -1,836,818 |
| Operating Margins | -4.44588 |
| Prev Name | Breeze Holdings Acquisition Corp. |
| Previous Close | 0.24 |
| Price Hint | 4 |
| Price To Book | 0.054692626 |
| Profit Margins | -2.76581 |
| Quick Ratio | 12.906 |
| Quote Source Name | Delayed Quote |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | 0.010000005 |
| Regular Market Change Percent | 4.166669 |
| Regular Market Day High | 0.2561 |
| Regular Market Day Low | 0.25 |
| Regular Market Day Range | 0.25 - 0.2561 |
| Regular Market Open | 0.2561 |
| Regular Market Previous Close | 0.24 |
| Regular Market Price | 0.25 |
| Regular Market Time | 1,783,972,800 |
| Regular Market Volume | 2,631 |
| Return On Assets | -0.25432 |
| Return On Equity | -0.42689 |
| Revenue Growth | 0.956 |
| Revenue Per Share | 0.466 |
| Sand P52 Week Change | 0.20847368 |
| Sector | |
| Sector Key | |
| Short Name | YD Bio Limited Warrants |
| Source Interval | 15 |
| Symbol | YDESW |
| Total Cash | 3,132,298 |
| Total Cash Per Share | 2.173 |
| Total Debt | 22,265 |
| Total Revenue | 510,360 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Type Disp | Equity |
| Volume | 2,631 |
| Website | https://www.ydesgroup.com |
| Zip | 115,001 |